Industry Reports
Top Biopharma Companies Show A Dip In Market Cap For Q3
The market capitalization of the top 20 biopharmaceutical businesses worldwide has decreased by 9.1%, from $3.45 trillion in Q2 2022 to $3.14 trillion in Q3 2022, as a result of growing generic competition and a decline in demand for...
Drug Research
EMA Advocates For Recall of Pholcodine Drugs From EU Market
PRAC, EMA's safety committee, has completed its review of pholcodine-containing medications used to treat nonproductive (dry) cough in adults and children as well as cold and flu symptoms when combined with other active ingredients. PRAC has recommended that the...
Drug Research
Regulations And Directive Revisions For Human Medicines
What changes are in store for the European Human Medicines Directive and Regulation when it is amended at the end of 2022?
The current European Union (EU) regulatory framework was created in 1995, and the European Medicines Agency (EMA) now...
Drug Research
Vaccines Europe Undertakes Its First Regulatory Evaluation
With 100 vaccine candidates as of July 2022, Vaccines Europe has released its first pipeline evaluation of the 15 firms that make up its membership.
The analysis uncovered a pipeline that uses a variety of new technology platforms to address...
Drug Research
By 2028, Non-Vaccine mRNA Therapy Will Earn $2 Billion
A recent analysis from GlobalData estimates that by 2028, the approval of pipeline drugs will earn over $2 billion from five marketed messenger RNA (mRNA) non-vaccine products.
The analytics firm claimed that despite the fact that there are currently no...
News
Why You Should Consider MISS Over Traditional Spine Surgery
Traditional spine surgeries take hours, come with lengthy recovery times, and even have extraneous risks that a MISS surgery can bypass.
Back and spine surgery is a daunting treatment that can seem risky. However, if you have tried all other...
News
Etihad Cargo achieves IATA CEIV Pharma Recertification for pharmaceutical logistics
Etihad Cargo, the cargo and logistics arm of Etihad Aviation Group, has been awarded Center of Excellence for Independent Validators (CEIV) Pharma recertification by the International Air Transport Association (IATA). The carrier is one of only 37 airlines to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.